BARYCELA Inj.
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BARYCELA Inj., covering 2026-04-17 to 2026-04-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Immunogenicity and Safety After the First and Second Doses of MG1111 (BARYCELA Inj.) in Healthy Children Aged 12 Months to 12 Years [Phase 3]